. Maura Healey Kim Driscoll Marylou Sudders Mass. Public Health Larry Madoff People with cancer are among MA’s most vulnerable residents. They should not have to be over 65 or have a second comorbidity to get vaccinated NOW. Cancer + COVID = ⬆️ risk of hospitalization ⬆️ risk of death

Join us #patients/#caregivers 4 our ALKtALK w/ JessicaJLinMD & I.DagogoJackMD from MassGeneral Medicine to discuss their New Clinical Trial that is patient funded by @ALKLungCancer w/ @lungevity! This is the 2nd clinical trial funded by the charity! #hope #ResearchSavesLives #alkpositive

Great day of #lungcancer advocacy for the Massachusetts #VoicesSummit21 team! Fortunate to have the support of our members of Congress as we work to increase federal funding for research. Elizabeth Warren Ed Markey Rep. Jake Auchincloss 🟧 Lori Trahan Rep. Seth Moulton Rep. Stephen F. Lynch

First case of pregnancy on ALECTINIB, taken care of in Milan by wonderful MDT. Very delicate issue for young patients with oncogen-addicted NSCLC Marina Garassino Marina Garassino Fedro Peccatori MD, PhD @ all authors!!! authors.elsevier.com/c/1cpvX5Xq2QNL…

.@ALKLungCancer ALKFusion

“The dedicated, brilliant researchers studying lung cancer and working on new treatments give me so much hope. So many people have invested their careers in improving lung cancer outcomes, and they’ve already made a huge difference.” #LungCancerHopeMonth

Thank you Dave Bjork Chris Draft for raising lung cancer awareness Fenway Park today!! So great to meet some new #LungCancer warriors 💪and #CelebrateLife with old friends #LCAM #Hope #LCSM

Loved joining other #lungcancer community members in raising awareness Fenway Park yesterday! Anyone with 🫁 can get 🫁 cancer & everyone deserves support. Thanks Ted Wayman for coverage, Dave Bjork & Chris Draft for organizing, NanniLisa & Allan for ribbon-building! The White Ribbon Project™

Congrats JessicaJLinMD Justin Gainor I.DagogoJackMD Lecia Sequist, MD, MPH Dr. Inga T. Lennes and the MGH Thoracic Oncology team for their article on the phase 1/2 investigator-initiated trial of alectinib plus bevacizumab in ALK+ lung cancer.

Help advance understanding of @ALKLungCancer

There's still time to apply! #LCSM

I'm excited to be involved in this new partnership between ALK Positive @ALKLungCancer and Lung Cancer Research Foundation ! lungcancerresearchfoundation.org/lcrf-and-alk-p… Letters of Intent accepted through May 9 - please apply! #lcsm

If you haven't signed up for tomorrow's ALK #lungcancer webinar, don't worry there is still time. Save your spot now to hear from Dr. Amy Moore, Dr. Sofia Merajver, Dr. Peggy Hsu, Dr. Angel Qin, & Amanda Nerstad, VP of ALK Positive Inc. at 1pm EST. bit.ly/3wEmgX9

I’ve contacted my representatives, Rep. Jake Auchincloss 🟧 Elizabeth Warren Ed Markey, asking for their support for increased lung cancer research funding. Please do the same! It only takes a couple of minutes.

Thank you CathyMcMorrisRodgers Rep. Frank Pallone Rep. Brett Guthrie @RepAnnaEshoofor including H.R. 4534, Women and Lung Cancer Research and Preventive Services Act at today's Energy and Commerce Committee hearing. Support this bill in the fight against lung cancer. #saveherlungs #lcsm

Wonderful to so see so many members & friends of our ALK+ community from all around the world at IASLC #WCLC24!

Dr. Tony Mok shares additional insights from CROWN, on pts w/ ALK+ nsclc who progressed early vs late on 1L lorlatinib, subsequent therapies. Critical to have these updates as the follow-up increases. #WCLC24 IASLC ALK Positive ALK+ International

Honored to be part of the IASLC STARS research advocacy program at #WCLC24. Meeting + learning from advocates from all over the 🌎 made my 1st WCLC great! Thanks to STARS mentors for making it possible! Dr Anne-Marie Baird Janet Freeman-Daily Jill Feldman Lillian Leigh GAICD A Ciupek, U Basu Roy

We are pleased to share this article out today in Cancer Discovery on the preclinical development and proof-of-concept clinical activity of NVL-655 ✅4th-generation, #ALK-selective TKI ✅CNS-penetrant ✅Broad coverage of ALK fusions and mutations, including lorlatinib-refractory compound

We are officially ONE WEEK OUT from LUNGevity Foundation's #ILCSC24! I am so excited and humbled by our amazing lineup featuring leading #lungcancer doctors, #scientists and #advocates from around the world. Check out the speakers and then register for FREE! reg.eventmobi.com/ilcsc24/pages/…